Search results:
General Information
| Gene_Symbol | Gene_ID | Gene_Name | Chromosome | Alias |
|---|---|---|---|---|
| SPARC | 6678 | Secreted protein, acidic, cysteine-rich (osteonectin)  | 5 | ON  |
- Evidence
- Gene
- mRNA
- CDS
- Protein
- PTM
- Enzyme
- PPi
- Pathway
- Structural
- Domain
- Ontology
- SNP
- Drug
- External Links
Evidence Information
| Pubmed ID | Year | Sample Information | Techniques | Mechanism | Fold Change | Remark |
|---|---|---|---|---|---|---|
| 17397030    | 2007 | Cell line : DLD 1, HCT 8, HCT 116, LOVO, HT 29 Source : ATTC or the Korean Cell Line Bank (KCLB). Sample Type : CRC tumor and normal tissue No. of Sample : 20 Stage : - | Methylation specific PCR,Western blot analysis, Immunohistochemistry, real time RT-PCR | Methylation | - | Epigenetic gene silencing of SPARC is frequent in colon cancers, and that inactivation of SPARC is related to rapid progression of colon cancers. Methylation status of the CpG island of SPARC in 7 colon cancer cell lines and in 20 test set of colon cancer tissues were found. |
| 18458674    | 2008 | Cell line : - Source : - Sample Type : CRC tumor and normal tissue No. of Sample : 10 CRC tissue sample and 5 normal tissue Stage : - | DNA bisulfite sequencing, methylation-specific PCR, RT-PCR, Chromatin immunoprecipitation assay . | Methylation | - | Therapeutic utility of employing demethylating agents 5-Aza-2'deoxycytidine to improve response through augmentation of SPARC expression. |
| 22939997    | 2012 | Cell line : DLD 1, HCT 8, HCT 116, LOVO and HT 29 Source : ATCC, Korean Cell Line Bank and Tissue from Department of Pathology at Yonsei University, Seoul, Korea and Gastrointestinal Tumor Working Group Tissue Bank at Yonsei University Medical Center (Seoul, Korea). Sample Type : CRC tumor and normal tissue No. of Sample : 312 CRC tissue sample Stage : - | DNA bisulfite sequencing, methylation-specific PCR and Combined bisulfate restriction analysis (COBR | Methylation | - | SPARC is commonly dysregulated in GI malignancies. Inhibition of DNA methylation can reverse the silencing of SPARC. |
| 21818290    | 2011 | Cell line : - Source : - Sample Type : CRC tumor and normal tissue No. of Sample : 120 paired normal and stage I-IV CRCs. Stage : TNM Stag I-IV | Tissue microarray | Up-regulation | - | High SPARC and FOXP3 are associated with better disease outcome in stage II CRC and may be prognostic indicators of CSS. SPARC and FOXP3 expression were significantly greater in CRC than normal colon. SPARC expression was initially assessed in 120 paired normal and stage I-IV CRCs. |
Gene Details

| Gene Type | protein coding |
|---|---|
| Gene Family | - |
| Description | This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. [provided by RefSeq, Dec 2011]   |
| Chromosome | 5 |
| Location | 5q31.3-q32 |
| Start | 151661096   |
| End | 151687054   |
| Strand | -   |
| Gene Sequence |    Download   Select all |
| Length | 25959   |
| OMIM ID | 182120    |
| HGNC ID | HGNC:11219    |
| Unigene ID | Hs.111779    |
| Ensembl ID | ENSG00000113140    |
| PharmGKB ID | PA36055    |
mRNA Information
| mRNA ID | NM_003118.3 |
|---|---|
| Exon | join(1..190,10854..10923,12381..12443,13839..13926, 15361..15482,17271..17391,19455..19588,20546..20694, 22820..22968,23456..25959)   | mRNA Sequence |    Download   Select all |
| Length | 3604   |
CDS Information
| Location | join(10867..10923,12381..12443,13839..13926,15361..15482, 17271..17391,19455..19588,20546..20694,22820..22968, 23456..23484) |
|---|---|
| CDS Sequence |    Download   Select all |
| CCDS ID | CCDS4318.1 |    
Protein Information
| Protein ID | NP_003109.1 |
|---|---|
| Protein Name | Secreted protein, acidic, cysteine-rich (osteonectin) |
| Molecular Wt. (Da) | 32698 |
| Protein Sequence |    Download   Select all |
| Length | 303   |
| Uniprot ID | Q16643 |    
| Ensembl Protein ID | ENSP00000292385   |    
Post-translational Modification Information (Source : HPRD)
| Residue | Type | site |
|---|---|---|
| C | Disulfide Bridge | 101;123 |
| C | Disulfide Bridge | 112;149 |
| N | Glycosylation | 116 |
| C | Disulfide Bridge | 273;289 |
| C | Disulfide Bridge | 72;83 |
| C | Disulfide Bridge | 77;93 |
| N | Glycosylation | 88 |
| C | Disulfide Bridge | 95;130 |
| R | Proteolytic Cleavage | 195 |
| Q | Proteolytic Cleavage | 20 |
| C | Disulfide Bridge | 155;265 |
Enzyme Information
No matching records could be found.
PPi Information
(Click to view network : Source STRING)      View   
| Interactant Gene ID (Source: HPRD) | Gene Symbol | HPRD ID | Ref Seq ID | Technique | References |
|---|---|---|---|---|---|
| 1277 |    COL1A1 |    362 |    NP_000079.2 |    in vitro |    7034958    |
| 1278 |    COL1A2 |    363 |    NP_000080.2 |    in vitro |    7034958    |
| 1280 |    COL2A1 |    361 |    NP_001835.3 |    in vitro |    2745554    |
| 1281 |    COL3A1 |    365 |    NP_000081.1 |    in vitro |    2745554    |
| 1305 |    COL13A1 |    383 |    NP_005194.3 |    in vitro |    11956183    |
| 2335 |    FN1 |    626 |    NP_997647.1 |    in vitro |    2745554    |
| 3339 |    HSPG2 |    804 |    NP_005520.4 |    in vitro |    2745554    |
| 5154 |    PDGFA |    1424 |    NP_002598.4 |    in vitro |    1311092    |
| 5327 |    PLAT |    1419 |    NP_000921.1 |    in vitro |    2745554    |
| 5340 |    PLG |    1417 |    NP_000292.1 |    in vitro |    27   455   547   982   919    |
| 6383 |    SDC2 |    803 |    NP_002989.2 |    in vitro |    2745554    |
Pathway Information
No matching records could be found.
Structure Information
| PDB ID | 1BMO |
|---|---|
| Resolution | 3.1 |
| Method | X-RAY DIFFRACTION |
| Chains | A,B   |
| Molecule | BM-40   |
| Model | View |
Domain Information
| ID | Location | Description |
|---|---|---|
| cd00252 | 154-301  | SPARC_EC |
| cl22905 | 154-301  | SPARC_EC superfamily |
| cd01328 | 71-152  | FSL_SPARC |
| cl00097 | 71-152  | KAZAL_FS superfamily |
| pfam10591 | 153-289  | SPARC_Ca_bdg |
| pfam00050 | 95-149  | Kazal_1 |
| pfam09289 | 72-93  | FOLN |
| cl23022 | 72-93  | FOLN superfamily |
| smart00274 | 71-94  | FOLN |
| cl23052 | 71-94  | FOLN superfamily |
| smart00280 | 98-149  | KAZAL |
| pfam07648 | 101-149  | Kazal_2 |
| cd00104 | 101-149  | KAZAL_FS |
Ontology Information
| HPRD ID | 145 |    
|---|---|
| Molecular Class | Secreted polypeptide |
| Molecular Function | Carboxy-lyase activity (GO:0016831) |
| Biological Process | Metabolism (GO:0008152); Energy pathways (GO:0006091)   |
Drug Information
No matching records could be found.
External Links
| ArrayExpress | GO |    
|---|---|
| ICGC | GO |    
| Cancer3D | GO |    
| COSMIC | GO |    
| NCG | GO |    
| TSGene | GO |    
| Tumor Gene Family of Databases | GO |    
| CCDB | GO |    
| G2SBC | GO |    
| Osteosarcoma Database | GO |    
| RCDB | GO |    
